HEADER HORMONE/GROWTH FACTOR 30-MAY-05 1ZUC TITLE PROGESTERONE RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH TITLE 2 THE NONSTEROIDAL AGONIST TANAPROGET COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROGESTERONE RECEPTOR; COMPND 3 CHAIN: B, A; COMPND 4 SYNONYM: PR; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PGR, NR3C3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX2T KEYWDS PROGESTERONE RECEPTOR, NONSTEROIDAL AGONIST, TANAPROGET, KEYWDS 2 PROGESTERONE, HORMONE, HORMONE/GROWTH FACTOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Z.ZHANG,A.M.OLLAND,Y.ZHU,J.COHEN,T.BERRODIN,S.CHIPPARI, AUTHOR 2 C.APPAVU,S.LI,J.WILHEM,R.CHOPRA,A.FENSOME,P.ZHANG,J.WROBEL, AUTHOR 3 R.J.UNWALLA,C.R.LYTTLE,R.C.WINNEKER REVDAT 3 24-FEB-09 1ZUC 1 VERSN REVDAT 2 09-AUG-05 1ZUC 1 JRNL REVDAT 1 05-JUL-05 1ZUC 0 JRNL AUTH Z.ZHANG,A.M.OLLAND,Y.ZHU,J.COHEN,T.BERRODIN, JRNL AUTH 2 S.CHIPPARI,C.APPAVU,S.LI,J.WILHEM,R.CHOPRA, JRNL AUTH 3 A.FENSOME,P.ZHANG,J.WROBEL,R.J.UNWALLA,C.R.LYTTLE, JRNL AUTH 4 R.C.WINNEKER JRNL TITL MOLECULAR AND PHARMACOLOGICAL PROPERTIES OF A JRNL TITL 2 POTENT AND SELECTIVE NOVEL NONSTEROIDAL JRNL TITL 3 PROGESTERONE RECEPTOR AGONIST TANAPROGET JRNL REF J.BIOL.CHEM. V. 280 28468 2005 JRNL REFN ISSN 0021-9258 JRNL PMID 15937332 JRNL DOI 10.1074/JBC.M504144200 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 33082 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.181 REMARK 3 R VALUE (WORKING SET) : 0.179 REMARK 3 FREE R VALUE : 0.228 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1737 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2360 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.83 REMARK 3 BIN R VALUE (WORKING SET) : 0.1960 REMARK 3 BIN FREE R VALUE SET COUNT : 116 REMARK 3 BIN FREE R VALUE : 0.2620 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4070 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 47 REMARK 3 SOLVENT ATOMS : 179 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.51 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.77000 REMARK 3 B22 (A**2) : -0.55000 REMARK 3 B33 (A**2) : -1.06000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.84000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.189 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.167 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.107 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.735 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.952 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.925 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4208 ; 0.018 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5698 ; 1.583 ; 1.997 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 500 ; 5.254 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 176 ;36.138 ;24.432 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 798 ;14.465 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 20 ;17.500 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 646 ; 0.105 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3064 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1968 ; 0.214 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2927 ; 0.305 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 203 ; 0.134 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 68 ; 0.261 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 16 ; 0.202 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2621 ; 1.233 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4084 ; 1.856 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1887 ; 2.963 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1614 ; 4.244 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS REMARK 4 REMARK 4 1ZUC COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-JUN-05. REMARK 100 THE RCSB ID CODE IS RCSB033128. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-SEP-02 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34825 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1A28 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.59 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, MGSO4, PIPES PH 6.5, REMARK 280 GLYCEROL, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 32.24850 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC REMARK 300 ASYMMETRIC UNIT WHICH CONSISTS OF 2 CHAIN(S). IT IS NOT KNOWN REMARK 300 WHETHER THE DIMER IN THE SAYMMETRIC UNIT IS ACTUALLY THE REMARK 300 BIOLOGICAL UNIT. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY B 675 REMARK 465 SER B 676 REMARK 465 PRO B 677 REMARK 465 GLY B 678 REMARK 465 GLN B 679 REMARK 465 ASP B 680 REMARK 465 ILE B 681 REMARK 465 LYS B 933 REMARK 465 GLY A 675 REMARK 465 SER A 676 REMARK 465 PRO A 677 REMARK 465 GLY A 678 REMARK 465 GLN A 679 REMARK 465 ASP A 680 REMARK 465 ILE A 681 REMARK 465 LYS A 933 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP B 704 CB - CG - OD1 ANGL. DEV. = -5.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN B 705 -16.79 73.80 REMARK 500 SER B 793 -14.91 91.96 REMARK 500 SER B 837 49.84 -105.04 REMARK 500 MET B 924 42.47 -95.15 REMARK 500 THR A 706 -73.41 -34.54 REMARK 500 MET A 789 74.27 -111.57 REMARK 500 SER A 837 57.27 -96.41 REMARK 500 ALA A 922 1.15 -66.73 REMARK 500 MET A 924 38.20 -93.67 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 203 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE T98 A 201 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE T98 B 202 DBREF 1ZUC A 675 933 UNP P06401 PRGR_HUMAN 675 933 DBREF 1ZUC B 675 933 UNP P06401 PRGR_HUMAN 675 933 SEQADV 1ZUC GLY A 675 UNP P06401 CLONING ARTIFACT SEQADV 1ZUC GLY B 675 UNP P06401 CLONING ARTIFACT SEQRES 1 B 259 GLY SER PRO GLY GLN ASP ILE GLN LEU ILE PRO PRO LEU SEQRES 2 B 259 ILE ASN LEU LEU MET SER ILE GLU PRO ASP VAL ILE TYR SEQRES 3 B 259 ALA GLY HIS ASP ASN THR LYS PRO ASP THR SER SER SER SEQRES 4 B 259 LEU LEU THR SER LEU ASN GLN LEU GLY GLU ARG GLN LEU SEQRES 5 B 259 LEU SER VAL VAL LYS TRP SER LYS SER LEU PRO GLY PHE SEQRES 6 B 259 ARG ASN LEU HIS ILE ASP ASP GLN ILE THR LEU ILE GLN SEQRES 7 B 259 TYR SER TRP MET SER LEU MET VAL PHE GLY LEU GLY TRP SEQRES 8 B 259 ARG SER TYR LYS HIS VAL SER GLY GLN MET LEU TYR PHE SEQRES 9 B 259 ALA PRO ASP LEU ILE LEU ASN GLU GLN ARG MET LYS GLU SEQRES 10 B 259 SER SER PHE TYR SER LEU CYS LEU THR MET TRP GLN ILE SEQRES 11 B 259 PRO GLN GLU PHE VAL LYS LEU GLN VAL SER GLN GLU GLU SEQRES 12 B 259 PHE LEU CYS MET LYS VAL LEU LEU LEU LEU ASN THR ILE SEQRES 13 B 259 PRO LEU GLU GLY LEU ARG SER GLN THR GLN PHE GLU GLU SEQRES 14 B 259 MET ARG SER SER TYR ILE ARG GLU LEU ILE LYS ALA ILE SEQRES 15 B 259 GLY LEU ARG GLN LYS GLY VAL VAL SER SER SER GLN ARG SEQRES 16 B 259 PHE TYR GLN LEU THR LYS LEU LEU ASP ASN LEU HIS ASP SEQRES 17 B 259 LEU VAL LYS GLN LEU HIS LEU TYR CYS LEU ASN THR PHE SEQRES 18 B 259 ILE GLN SER ARG ALA LEU SER VAL GLU PHE PRO GLU MET SEQRES 19 B 259 MET SER GLU VAL ILE ALA ALA GLN LEU PRO LYS ILE LEU SEQRES 20 B 259 ALA GLY MET VAL LYS PRO LEU LEU PHE HIS LYS LYS SEQRES 1 A 259 GLY SER PRO GLY GLN ASP ILE GLN LEU ILE PRO PRO LEU SEQRES 2 A 259 ILE ASN LEU LEU MET SER ILE GLU PRO ASP VAL ILE TYR SEQRES 3 A 259 ALA GLY HIS ASP ASN THR LYS PRO ASP THR SER SER SER SEQRES 4 A 259 LEU LEU THR SER LEU ASN GLN LEU GLY GLU ARG GLN LEU SEQRES 5 A 259 LEU SER VAL VAL LYS TRP SER LYS SER LEU PRO GLY PHE SEQRES 6 A 259 ARG ASN LEU HIS ILE ASP ASP GLN ILE THR LEU ILE GLN SEQRES 7 A 259 TYR SER TRP MET SER LEU MET VAL PHE GLY LEU GLY TRP SEQRES 8 A 259 ARG SER TYR LYS HIS VAL SER GLY GLN MET LEU TYR PHE SEQRES 9 A 259 ALA PRO ASP LEU ILE LEU ASN GLU GLN ARG MET LYS GLU SEQRES 10 A 259 SER SER PHE TYR SER LEU CYS LEU THR MET TRP GLN ILE SEQRES 11 A 259 PRO GLN GLU PHE VAL LYS LEU GLN VAL SER GLN GLU GLU SEQRES 12 A 259 PHE LEU CYS MET LYS VAL LEU LEU LEU LEU ASN THR ILE SEQRES 13 A 259 PRO LEU GLU GLY LEU ARG SER GLN THR GLN PHE GLU GLU SEQRES 14 A 259 MET ARG SER SER TYR ILE ARG GLU LEU ILE LYS ALA ILE SEQRES 15 A 259 GLY LEU ARG GLN LYS GLY VAL VAL SER SER SER GLN ARG SEQRES 16 A 259 PHE TYR GLN LEU THR LYS LEU LEU ASP ASN LEU HIS ASP SEQRES 17 A 259 LEU VAL LYS GLN LEU HIS LEU TYR CYS LEU ASN THR PHE SEQRES 18 A 259 ILE GLN SER ARG ALA LEU SER VAL GLU PHE PRO GLU MET SEQRES 19 A 259 MET SER GLU VAL ILE ALA ALA GLN LEU PRO LYS ILE LEU SEQRES 20 A 259 ALA GLY MET VAL LYS PRO LEU LEU PHE HIS LYS LYS HET SO4 A 203 5 HET T98 A 201 21 HET T98 B 202 21 HETNAM SO4 SULFATE ION HETNAM T98 5-(4,4-DIMETHYL-2-THIOXO-1,4-DIHYDRO-2H-3,1- HETNAM 2 T98 BENZOXAZIN-6-YL)-1-METHYL-1H-PYRROLE-2-CARBONITRILE HETSYN T98 TANAPROGET FORMUL 3 SO4 O4 S 2- FORMUL 4 T98 2(C16 H15 N3 O S) FORMUL 6 HOH *179(H2 O) HELIX 1 1 PRO B 685 ILE B 694 1 10 HELIX 2 2 THR B 710 LEU B 736 1 27 HELIX 3 3 GLY B 738 LEU B 742 5 5 HELIX 4 4 HIS B 743 SER B 772 1 30 HELIX 5 5 ASN B 785 GLU B 791 1 7 HELIX 6 6 PHE B 794 GLN B 812 1 19 HELIX 7 7 SER B 814 LEU B 827 1 14 HELIX 8 8 SER B 837 LEU B 858 1 22 HELIX 9 9 GLY B 862 GLN B 897 1 36 HELIX 10 10 GLN B 897 SER B 902 1 6 HELIX 11 11 PRO B 906 ALA B 922 1 17 HELIX 12 12 PRO A 685 ILE A 694 1 10 HELIX 13 13 THR A 710 LEU A 736 1 27 HELIX 14 14 GLY A 738 LEU A 742 5 5 HELIX 15 15 HIS A 743 SER A 772 1 30 HELIX 16 16 ASN A 785 MET A 789 5 5 HELIX 17 17 GLU A 791 GLN A 812 1 22 HELIX 18 18 SER A 814 LEU A 827 1 14 HELIX 19 19 SER A 837 LEU A 858 1 22 HELIX 20 20 GLY A 862 GLN A 897 1 36 HELIX 21 21 GLN A 897 SER A 902 1 6 HELIX 22 22 PRO A 906 ALA A 922 1 17 SHEET 1 A 2 LEU B 776 ALA B 779 0 SHEET 2 A 2 LEU B 782 LEU B 784 -1 O LEU B 784 N LEU B 776 SHEET 1 B 2 THR B 829 ILE B 830 0 SHEET 2 B 2 LYS B 926 PRO B 927 -1 O LYS B 926 N ILE B 830 SHEET 1 C 2 LEU A 776 ALA A 779 0 SHEET 2 C 2 LEU A 782 LEU A 784 -1 O LEU A 784 N LEU A 776 SHEET 1 D 2 THR A 829 PRO A 831 0 SHEET 2 D 2 VAL A 925 PRO A 927 -1 O LYS A 926 N ILE A 830 SITE 1 AC1 9 PRO A 737 GLY A 738 ARG A 740 ASN A 741 SITE 2 AC1 9 HOH B 176 PRO B 737 GLY B 738 ARG B 740 SITE 3 AC1 9 ASN B 741 SITE 1 AC2 10 LEU A 718 ASN A 719 GLN A 725 MET A 759 SITE 2 AC2 10 ARG A 766 PHE A 778 LEU A 797 TYR A 890 SITE 3 AC2 10 THR A 894 PHE A 905 SITE 1 AC3 8 LEU B 718 ASN B 719 GLN B 725 MET B 759 SITE 2 AC3 8 ARG B 766 LEU B 797 TYR B 890 THR B 894 CRYST1 57.519 64.497 70.406 90.00 95.76 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017386 0.000000 0.001753 0.00000 SCALE2 0.000000 0.015505 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014275 0.00000 MASTER 299 0 3 22 8 0 8 6 0 0 0 40 END